Myocardial Involvement During Ischemia-Induced Acute Liver Failure in the Pig

被引:3
作者
Tsaroucha, Athanasia [1 ]
Chondrogiannis, Constantinos [1 ]
Mani, Alexia [1 ]
Staikou, Chryssoula [1 ]
机构
[1] Aretaieio Hosp, Dept Anesthesiol, Athens 11634, Greece
关键词
acute liver failure; myocardial damage; cardiac troponin; CK-MB; CARDIAC TROPONIN-I; FULMINANT;
D O I
10.3109/08941939.2012.705953
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: The objective of this experimental study was to investigate a possible myocardial involvement in acute liver failure. Materials and Methods: A porcine model of acute liver failure induced by hepatic devascularization was used. Twenty animals were allocated to the Acute Liver Failure (ALF) or Control Group (CG). Serum cardiac troponin I (cTnI), MB isoenzyme of creatine kinase (CK-MB), and also hemodynamic variables were measured and compared before surgery (T-1), at 4 hr (T-2), and at 7 hr (T-3) after the end of surgery. Results: Data from 10 pigs in the ALF and 7 in the CG were analyzed. In the ALF group, cTnI increased from 0.3 +/- 0.055 to 0.35 +/- 0.696 and 0.39 +/- 0.06 ng/ml at T-1, T-2, and T-3 time points, respectively (p < .001). In the CG, cTnI was not significantly changed from 0.29 +/- 0.07, to 0.31 +/- 0.01, and 0.31 +/- 0.11 ng/ml at T-1, T-2, and T-3 time points, respectively (p = .895). A statistically significant difference was found in cTnI between the groups at T-3 (z = -2.93, p = .002). CK-MB increased significantly in both groups: in ALF group, CK-MB changed from 3.43 +/- 0.53 to 4.33 +/- 0.73 and 7.14 +/- 1.12 ng/ml at T-1, T-2, and T-3 time points, respectively (p < .001). In the CG, CK-MB changed from 3.6 +/- 0.597 to 4.6 +/- 1.07 and 6.2 +/- 1.17 ng/ml at T-1, T-2, and T-3 time points, respectively, (p = .001). Mean arterial pressure (MAP) was significantly reduced in the ALF group. Conclusions: In a porcine model of acute liver failure, a significant increase of cTnI serum levels was found, indicating that a subclinical myocardial damage may occur as a result of heart involvement in the multiple organ dysfunction.
引用
收藏
页码:99 / 104
页数:6
相关论文
共 28 条
[1]   CARDIAC TROPONIN-I - A MARKER WITH HIGH SPECIFICITY FOR CARDIAC INJURY [J].
ADAMS, JE ;
BODOR, GS ;
DAVILAROMAN, VG ;
DELMEZ, JA ;
APPLE, FS ;
LADENSON, JH ;
JAFFE, AS .
CIRCULATION, 1993, 88 (01) :101-106
[2]   Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes [J].
Ammann, P ;
Maggiorini, M ;
Bertel, O ;
Haenseler, E ;
Joller-Jemelka, HI ;
Oechslin, E ;
Minder, EI ;
Rickli, H ;
Fehr, T .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (11) :2004-2009
[3]   PARACETAMOL CARDIOTOXICITY [J].
ARMOUR, A ;
SLATER, SD .
POSTGRADUATE MEDICAL JOURNAL, 1993, 69 (807) :52-54
[4]   Acute liver failure; clinical features and management [J].
Bernal, W ;
Wendon, J .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1999, 11 (09) :977-984
[5]   Fulminant hepatic failure [J].
Bernstein, D ;
Tripodi, J .
CRITICAL CARE CLINICS, 1998, 14 (02) :181-+
[6]   FULMINANT AND SUBFULMINANT LIVER-FAILURE - DEFINITIONS AND CAUSES [J].
BERNUAU, J ;
RUEFF, B ;
BENHAMOU, JP .
SEMINARS IN LIVER DISEASE, 1986, 6 (02) :97-106
[7]  
Bhagavan NV, 1998, J CLIN LAB ANAL, V12, P276, DOI 10.1002/(SICI)1098-2825(1998)12:5<276::AID-JCLA4>3.3.CO
[8]  
2-Q
[9]  
BODOR GS, 1995, CLIN CHEM, V41, P1710
[10]  
Collins JN, 2001, AM SURGEON, V67, P821